Who are Regentis's investors?

Regentis's investors include SCP Vitalife Partners.

How much funding has Regentis raised?

Regentis has disclosed $6.5M raised across 1 round.

Where is Regentis headquartered?

Regentis is headquartered in Herzliya, IL.

Regentis

Herzliya, IL · 1 known investors

Regentis Biomaterials develops regenerative medicine products for tissue repair, focused on orthopedic cartilage and bone treatments through its Gelrin degradable hydrogel platform. Its lead product, GelrinC, is a cell-free hydrogel implant for repairing articular knee cartilage injuries, CE-marked in Europe and in US clinical trials toward PMA approval.</parameter> <parameter name="founders">[]

Biotech Healthtech Medical Devices

Founders & leadership

Galit ReskeExecutive

Arie GordashnikovExecutive

Ori GonExecutive

Board

Jeff Dykan inBoard directorPartner at SCP Vitalife Partners

Ehud GellerBoard director

Susan AlpertBoard director

Pini Ben-ElazarBoard director

Keith ValentineBoard director

Efraim Cohen-AraziBoard director

Investors · 1

SCP Vitalife PartnersTel Aviv · $3M – $7M

Reported raises · per SEC filings

Form D private placements

$6.5M disclosed across 1 round · 2026

▶$6.5MraisedJun 2026 · 22 investors · Biotechnology

Rule 506(c)

Officers, directors & promoters on the filing

Galit ReskeExecutive Officer
Arie GordashnikovExecutive Officer
Susan AlpertDirector
Pini Ben-ElazarDirector
Keith ValentineDirector
Efraim Cohen-AraziDirector
Jeff DykanDirector
Ori GonExecutive Officer
Ehud GellerExecutive Officer, Director

Offering amount: $6.5M
Amount sold: $6.5M
Sales commissions: $455K
Placement agents: ThinkEquity LLC
First sale: Jun 2026
Incorporated: Corporation, Israel
Federal exemptions: 06c

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

TradingView3 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.

Companies competing with Regentis for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Regentis do?: Regentis Biomaterials develops regenerative medicine products for tissue repair, focused on orthopedic cartilage and bone treatments through its Gelrin degradable hydrogel platform. Its lead product, GelrinC, is a cell-free hydrogel implant for repairing articular knee cartilage injuries, CE-marked in Europe and in US clinical trials toward PMA approval.</parameter> <parameter name="founders">[]
Who are Regentis's investors?: Regentis's investors include SCP Vitalife Partners.
How much funding has Regentis raised?: Regentis has disclosed $6.5M raised across 1 round.
Where is Regentis headquartered?: Regentis is headquartered in Herzliya, IL.